vs

Side-by-side financial comparison of Donnelley Financial Solutions, Inc. (DFIN) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.

Donnelley Financial Solutions, Inc. is the larger business by last-quarter revenue ($172.5M vs $168.4M, roughly 1.0× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 10.4%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -7.9%).

Donnelley Financial Solutions (DFIN) is a financial compliance company based in Chicago, Illinois, United States. The company provides software as a service (SaaS) products, software-enabled services (SeS), print, and compliance services related to US Securities and Exchange Commission regulations to companies in capital and investment markets.

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

DFIN vs ESPR — Head-to-Head

Bigger by revenue
DFIN
DFIN
1.0× larger
DFIN
$172.5M
$168.4M
ESPR
Growing faster (revenue YoY)
ESPR
ESPR
+133.4% gap
ESPR
143.7%
10.4%
DFIN
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
-7.9%
DFIN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DFIN
DFIN
ESPR
ESPR
Revenue
$172.5M
$168.4M
Net Profit
$6.2M
Gross Margin
Operating Margin
8.3%
50.6%
Net Margin
3.6%
Revenue YoY
10.4%
143.7%
Net Profit YoY
-1.6%
EPS (diluted)
$0.31
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DFIN
DFIN
ESPR
ESPR
Q4 25
$172.5M
$168.4M
Q3 25
$175.3M
$87.3M
Q2 25
$218.1M
$82.4M
Q1 25
$201.1M
$65.0M
Q4 24
$156.3M
$69.1M
Q3 24
$179.5M
$51.6M
Q2 24
$242.7M
$73.8M
Q1 24
$203.4M
$137.7M
Net Profit
DFIN
DFIN
ESPR
ESPR
Q4 25
$6.2M
Q3 25
$-40.9M
$-31.3M
Q2 25
$36.1M
$-12.7M
Q1 25
$31.0M
$-40.5M
Q4 24
$6.3M
Q3 24
$8.7M
$-29.5M
Q2 24
$44.1M
$-61.9M
Q1 24
$33.3M
$61.0M
Operating Margin
DFIN
DFIN
ESPR
ESPR
Q4 25
8.3%
50.6%
Q3 25
16.1%
-11.4%
Q2 25
24.2%
8.6%
Q1 25
22.8%
-34.0%
Q4 24
6.0%
-6.4%
Q3 24
10.1%
-31.0%
Q2 24
26.6%
3.5%
Q1 24
21.9%
52.5%
Net Margin
DFIN
DFIN
ESPR
ESPR
Q4 25
3.6%
Q3 25
-23.3%
-35.9%
Q2 25
16.6%
-15.4%
Q1 25
15.4%
-62.2%
Q4 24
4.0%
Q3 24
4.8%
-57.2%
Q2 24
18.2%
-83.9%
Q1 24
16.4%
44.3%
EPS (diluted)
DFIN
DFIN
ESPR
ESPR
Q4 25
$0.31
$0.32
Q3 25
$-1.49
$-0.16
Q2 25
$1.28
$-0.06
Q1 25
$1.05
$-0.21
Q4 24
$0.21
$-0.14
Q3 24
$0.29
$-0.15
Q2 24
$1.47
$-0.33
Q1 24
$1.09
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DFIN
DFIN
ESPR
ESPR
Cash + ST InvestmentsLiquidity on hand
$24.5M
$167.9M
Total DebtLower is stronger
$171.3M
Stockholders' EquityBook value
$379.2M
$-302.0M
Total Assets
$800.4M
$465.9M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DFIN
DFIN
ESPR
ESPR
Q4 25
$24.5M
$167.9M
Q3 25
$22.7M
$92.4M
Q2 25
$33.8M
$86.1M
Q1 25
$16.2M
$114.6M
Q4 24
$57.3M
$144.8M
Q3 24
$33.6M
$144.7M
Q2 24
$35.0M
$189.3M
Q1 24
$43.7M
$226.6M
Total Debt
DFIN
DFIN
ESPR
ESPR
Q4 25
$171.3M
Q3 25
$154.7M
Q2 25
$190.1M
Q1 25
$189.5M
Q4 24
$124.7M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DFIN
DFIN
ESPR
ESPR
Q4 25
$379.2M
$-302.0M
Q3 25
$423.1M
$-451.4M
Q2 25
$432.1M
$-433.5M
Q1 25
$419.9M
$-426.2M
Q4 24
$436.1M
$-388.7M
Q3 24
$444.5M
$-370.2M
Q2 24
$441.5M
$-344.2M
Q1 24
$408.9M
$-294.3M
Total Assets
DFIN
DFIN
ESPR
ESPR
Q4 25
$800.4M
$465.9M
Q3 25
$816.3M
$364.0M
Q2 25
$874.7M
$347.1M
Q1 25
$852.8M
$324.0M
Q4 24
$841.6M
$343.8M
Q3 24
$843.6M
$314.1M
Q2 24
$882.9M
$352.3M
Q1 24
$867.8M
$373.1M
Debt / Equity
DFIN
DFIN
ESPR
ESPR
Q4 25
0.45×
Q3 25
0.37×
Q2 25
0.44×
Q1 25
0.45×
Q4 24
0.29×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DFIN
DFIN
ESPR
ESPR
Operating Cash FlowLast quarter
$59.8M
$45.2M
Free Cash FlowOCF − Capex
$47.9M
FCF MarginFCF / Revenue
27.8%
Capex IntensityCapex / Revenue
6.9%
0.0%
Cash ConversionOCF / Net Profit
9.65×
TTM Free Cash FlowTrailing 4 quarters
$107.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DFIN
DFIN
ESPR
ESPR
Q4 25
$59.8M
$45.2M
Q3 25
$74.4M
$-4.3M
Q2 25
$68.4M
$-31.4M
Q1 25
$-37.7M
$-22.6M
Q4 24
$56.4M
$-35.0M
Q3 24
$86.4M
$-35.3M
Q2 24
$56.2M
$-7.2M
Q1 24
$-27.9M
$53.8M
Free Cash Flow
DFIN
DFIN
ESPR
ESPR
Q4 25
$47.9M
Q3 25
$59.2M
Q2 25
$51.7M
Q1 25
$-51.0M
Q4 24
$41.3M
Q3 24
$67.3M
$-35.5M
Q2 24
$36.8M
$-7.3M
Q1 24
$-40.2M
$53.8M
FCF Margin
DFIN
DFIN
ESPR
ESPR
Q4 25
27.8%
Q3 25
33.8%
Q2 25
23.7%
Q1 25
-25.4%
Q4 24
26.4%
Q3 24
37.5%
-68.7%
Q2 24
15.2%
-9.9%
Q1 24
-19.8%
39.0%
Capex Intensity
DFIN
DFIN
ESPR
ESPR
Q4 25
6.9%
0.0%
Q3 25
8.7%
0.0%
Q2 25
7.7%
0.0%
Q1 25
6.6%
0.0%
Q4 24
9.7%
0.0%
Q3 24
10.6%
0.3%
Q2 24
8.0%
0.1%
Q1 24
6.0%
0.1%
Cash Conversion
DFIN
DFIN
ESPR
ESPR
Q4 25
9.65×
Q3 25
Q2 25
1.89×
Q1 25
-1.22×
Q4 24
8.95×
Q3 24
9.93×
Q2 24
1.27×
Q1 24
-0.84×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DFIN
DFIN

Technology Service$68.0M39%
Capital Markets Compliance And Communications Management$61.6M36%
Investment Companies Software Solutions$30.9M18%
Print And Distribution Service$13.6M8%

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

Related Comparisons